GAMMA Investing’s Cabaletta Bio CABA Stock Holding History

GAMMA Investing’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.1K	Buy	+1,095	New	+$3.09K	﹤0.01%	3943
2024 Q3	–	Sell	-12	Closed	-$90	–	3596
2024 Q2	$90	Buy	12 +9	+300%	+$110	﹤0.01%	3408
2024 Q1	$51	Sell	3 -11	-79%	-$236	﹤0.01%	3290
2023 Q4	$287	Buy	+14	New	+$235	﹤0.01%	3072

Other funds holding CABA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's CABA Position: Q3 2026 in Review

GAMMA Investing opened a new position in Cabaletta Bio (CABA) in Q3 2026: 1,095 shares worth $2.1K. The stake represents ﹤0.01% of the portfolio and ranks #3943 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in CABA as recently as Q2 2024.

GAMMA Investing first reported a position in CABA in Q4 2023 and has held it in 4 quarters since. 2 funds tracked by Wall St. Rank hold CABA as of Q3 2026.

GAMMA Investing held 1,095 shares of Cabaletta Bio worth $2.1K as of Q3 2026.
Cabaletta Bio was a new GAMMA Investing position in Q3 2026.
Cabaletta Bio made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3943 holding.
GAMMA Investing first reported a position in Cabaletta Bio in Q4 2023 and has held it in 4 quarters since.
2 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.